Tamm-Horsfall protein facilitates catheter associated urinary tract infection

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Raffi, Hajamohideen S ^a   Bates, James M ^a   Flournoy, Dayl J ^a   Kumar, Satish ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacterial binding; Tamm Horsfall protein; Urinary catheters

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

LATEX; SILICONE DERIVATIVE; TAMM HORSFALL GLYCOPROTEIN; UMOD PROTEIN, HUMAN;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ADHERENCE; CATHETER; CATHETER INFECTION; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; TIME; URINARY TRACT INFECTION; URINE;

BACTERIAL ADHESION; BACTERIAL INFECTIONS; CATHETER-RELATED INFECTIONS; CATHETERS; ESCHERICHIA COLI; HOST-PATHOGEN INTERACTIONS; HUMANS; LATEX; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; SILICONES; TIME FACTORS; URINARY TRACT INFECTIONS; UROMODULIN;

EID: 84866551687     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-532     Document Type: Article

References (21)

1. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, Quade D, Shachtman RH, Schaberg DR, Shah BV, Schatz GD, Am J Med 1981 70 947 959 10.1016/0002-9343(81)90561-1 6938129
2. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Saint S, Am J Infect Control 2000 28 68 75 10.1016/S0196-6553(00) 90015-4 10679141
3. Catheter related urinary tract infections: epidemiology, pathogenesis and prevention. Stamm WE, Amer J Med 1991 91 65S 71S 10.1016/0002-9343(91)90345-X 1928194
4. Urinary tract infections: disease panorama and challenges. Stamm WE, Norrby SR, J Infect Dis 2001 183 1 S4 10.1086/318850 11171002
5. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Hartstein AI, Garber SB, Ward TT, Jones SR, Morthland VH, Infect Control 1981 2 380 386 6795141
6. Nosocomial infections in medical intensive care units in the United States. National nosocomial infections surveillance system. Richards MJ, Edwards JR, Culver DH, Gaynes RP, Crit Care Med 1999 27 887 892 10.1097/00003246- 199905000-00020 10362409
7. Tamm-horsfall protein-uromodulin (1950-1990). Kumar S, Muchmore A, Kidney Int 1990 37 1395 1401 10.1038/ki.1990.128 2194064
8. Tamm-horsfall glycoprotein: biology and clinical relevance. Serafini-Cessi F, Malagolini N, Cavallone D, Am J Kidney Dis 2003 42 658 676 10.1016/S0272-6386(03)00829-1 14520616
9. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O, Kidney Int 2011 80 338 347 10.1038/ki.2011.134 21654721
10. Tamm-horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S, Kidney Int 2004 65 791 797 10.1111/j.1523-1755.2004.00452.x 14871399
11. Ablation of the tamm-horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR, Am J Physiol Renal Physiol 2004 286 795 F802 10.1152/ajprenal.00357.2003 14665435
12. Role of biofilm in catheter-associated urinary tract infection. Trautner BW, Darouiche RO, Am J Infect Control 2004 32 177 183 10.1016/j.ajic.2003.08.005 15153930
13. A simple artificial urine for the growth of urinary pathogens. Brooks T, Keevil CW, Lett Appl Microbiol 1997 24 203 206 10.1046/j.1472-765X.1997.00378.x 9080700
14. A UK multicenter study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D, J Infect 2003 46 94 100 10.1053/jinf.2002.1091 12634070
15. Engineering out the risk for infection with urinary catheters. Maki DG, Tambyah PA, Emerg Infect Dis 2001 7 342 347 10.3201/eid0702.010240 11294737
16. A prospective study of pathogenesis of catheter associated urinary tract infections. Tambyah PA, Halvorson KT, Maki DG, Mayo Clin Proc 1999 74 131 136 10.4065/74.2.131 10069349
17. Tamm-horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Orskov I, Ferencz A, Orskov F, Lancet 1980 1 887 6103253
18. Tamm-horsfall protein binds to type 1fimbriated Escherichia coli and prevents E. Coli from binding to uroplakin Ia and Ib receptors. Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR, J Biol Chem 2001 276 9924 9930 10.1074/jbc.M008610200 11134021
19. Tamm-horsfall protein acts as a general host-defense factor against bacterial cystitis. Raffi HS, Bates JM Jr, Laszik Z, Kumar S, Am J Nephrol 2005 25 570 578 10.1159/000088990 16244464
20. Tamm-horsfall protein protects against urinary tract infection by Proteus mirabilis. Raffi HS, Bates JM Jr, Laszik Z, Kumar S, J Urol 2009 181 2332 2338 10.1016/j.juro.2009.01.014 19303096
21. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. Mobley HL, Chippendale GR, Tenney JH, Hull RA, Warren JW, J Clin Microbiol 1987 25 2253 2257 2892855